{"id":4582,"date":"2025-07-17T15:31:01","date_gmt":"2025-07-17T13:31:01","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=4582"},"modified":"2025-07-17T15:31:41","modified_gmt":"2025-07-17T13:31:41","slug":"ascertain-consortium-meeting-in-oslo","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/de\/ascertain-consortium-meeting-in-oslo\/","title":{"rendered":"ASCERTAIN Consortium Meeting in Oslo"},"content":{"rendered":"\n<p>On 30 June 2025, the ASCERTAIN Consortium held its Stakeholder Day in Oslo, bringing together experts from academia, healthcare, industry, and policy to discuss sustainable access to innovative health technologies (IHTs). The event focused on refining access-based pricing, cost-effectiveness, and reimbursement models by aligning them with stakeholder needs and expectations.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/07\/Group-photo-1-1024x768.jpeg\" alt=\"\" class=\"wp-image-4584\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/07\/Group-photo-1-980x735.jpeg 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/07\/Group-photo-1-480x360.jpeg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-setting-the-stage-why-ascertain-matters\">Setting the Stage: Why ASCERTAIN Matters<\/h4>\n\n\n\n<p>Carin Uyl-de Groot (Erasmus University Rotterdam) opened the meeting with an overview of ASCERTAIN\u2019s mission: to build a public, cloud-based tool that supports fair and sustainable access to IHTs. She highlighted the financial strain on healthcare systems, unequal access across the EU, growing uncertainty in clinical evidence, and the environmental impact of new therapies. The project focuses on three use cases: Precision Cancer Medicine, Cell and Gene Therapy, and Next Generation Sequencing.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-pricing-models-to-support-negotiations\">Pricing Models to Support Negotiations<\/h4>\n\n\n\n<p>Maximilian Salcher-Konrad (Gesundheit \u00d6sterreich) and Anne Hendrickx (AIM) presented a pricing model combining cost-based elements (e.g. R&amp;D, manufacturing) with value-based factors (e.g. clinical benefit, societal value). Their model, adaptable to different EU contexts, aims to support existing national processes. A key insight: treatment costs can vary significantly based on disease prevalence, a point illustrated through cancer drug scenarios.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-stakeholder-perspectives-on-pricing\">Stakeholder Perspectives on Pricing<\/h4>\n\n\n\n<p>Contributions from stakeholder organizations enriched the dialogue:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>EAHP emphasized the need for transparent pricing and practical tools for procurement.<\/li>\n\n\n\n<li>IKK e.V. proposed using the ASCERTAIN model to inform initial benchmark pricing in Germany\u2019s AMNOG process.<\/li>\n\n\n\n<li>EHA highlighted the growing affordability crisis, citing real-world examples of delayed patient access due to price disputes.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-global-cost-effectiveness-and-reimbursement-models\">Global Cost-Effectiveness and Reimbursement Models<\/h4>\n\n\n\n<p>Eline Aas (University of Oslo) introduced scalable cost-effectiveness models tailored to two user groups: technical experts and decision-makers. Modular structures and flexible parameters were key features to support international use and adaptation.<\/p>\n\n\n\n<p>Tom Belleman (Erasmus University Rotterdam) explained how ASCERTAIN\u2019s reimbursement models will evaluate Managed Entry Agreements (MEAs). These finance- and outcome-based agreements aim to reduce uncertainty and align payment with real-world results.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-hta-and-procurement-practical-needs-and-governance\">HTA and Procurement: Practical Needs and Governance<\/h4>\n\n\n\n<p>Industry and public stakeholders shared operational perspectives:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>AbbVie Scandinavia advocated for modular tools that are simple and transparent, while noting challenges like confidentiality.<\/li>\n\n\n\n<li>NoMA (Norway\u2019s HTA body) outlined the value of shared, open-source models for national and cross-border assessments.<\/li>\n\n\n\n<li>Sykehusinnkj\u00f8p stressed the importance of evolving prices based on post-launch data and called for MEAs that genuinely improve access.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-ascertain-policy-support-tool-designed-for-real-world-use\">ASCERTAIN Policy Support Tool: Designed for Real-World Use<\/h4>\n\n\n\n<p>Moritz Mumme and Pascal Wendel (OptiMedis) showcased the upcoming ASCERTAIN Policy Support Tool. Designed for both technical and non-technical users, the platform supports full or partial assessments using the project&#8217;s pricing, cost-effectiveness, and reimbursement models. Features include guided workflows, customizable sharing, parameter validation, and AI-assisted support.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-looking-ahead\">Looking Ahead<\/h4>\n\n\n\n<p>The Oslo meeting reaffirmed ASCERTAIN\u2019s commitment to transparency, collaboration, and practical impact. The consortium continues to refine its tools with input from diverse stakeholders and invites ongoing participation in user testing and co-creation.<\/p>\n\n\n\n<p>Interested in joining our next development sprint? Contact us to get involved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 30 June 2025, the ASCERTAIN Consortium held its Stakeholder Day in Oslo, bringing together experts from academia, healthcare, industry, and policy to discuss sustainable access to innovative health technologies (IHTs). The event focused on refining access-based pricing, cost-effectiveness, and reimbursement models by aligning them with stakeholder needs and expectations.<\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[21,14,22,23,20],"class_list":["post-4582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-health-technologies","tag-healthcare","tag-hta","tag-iht","tag-innovative-health-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ASCERTAIN Consortium Meeting in Oslo - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"We are happy to announce that the ASCERTAIN project website is now accessible in eight different languages:English, German, Dutch, Norwegian, Romanian, Croatian, Spanish, and French.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCERTAIN Consortium Meeting in Oslo\" \/>\n<meta property=\"og:description\" content=\"We are happy to announce that the ASCERTAIN project website is now accessible in eight different languages:English, German, Dutch, Norwegian, Romanian, Croatian, Spanish, and French.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-17T13:31:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T13:31:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"ASCERTAIN Consortium Meeting in Oslo\",\"datePublished\":\"2025-07-17T13:31:01+00:00\",\"dateModified\":\"2025-07-17T13:31:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/\"},\"wordCount\":496,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"health technologies\",\"healthcare\",\"HTA\",\"iht\",\"innovative health technologies\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/\",\"name\":\"ASCERTAIN Consortium Meeting in Oslo - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2025-07-17T13:31:01+00:00\",\"dateModified\":\"2025-07-17T13:31:41+00:00\",\"description\":\"We are happy to announce that the ASCERTAIN project website is now accessible in eight different languages:English, German, Dutch, Norwegian, Romanian, Croatian, Spanish, and French.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-consortium-meeting-in-oslo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASCERTAIN Consortium Meeting in Oslo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN Consortium Meeting in Oslo - ASCERTAIN","description":"We are happy to announce that the ASCERTAIN project website is now accessible in eight different languages:English, German, Dutch, Norwegian, Romanian, Croatian, Spanish, and French.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/","og_locale":"de_DE","og_type":"article","og_title":"ASCERTAIN Consortium Meeting in Oslo","og_description":"We are happy to announce that the ASCERTAIN project website is now accessible in eight different languages:English, German, Dutch, Norwegian, Romanian, Croatian, Spanish, and French.","og_url":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/","og_site_name":"ASCERTAIN","article_published_time":"2025-07-17T13:31:01+00:00","article_modified_time":"2025-07-17T13:31:41+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Verfasst von":"Lena Jessen","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"ASCERTAIN Consortium Meeting in Oslo","datePublished":"2025-07-17T13:31:01+00:00","dateModified":"2025-07-17T13:31:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/"},"wordCount":496,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["health technologies","healthcare","HTA","iht","innovative health technologies"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/","url":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/","name":"ASCERTAIN Consortium Meeting in Oslo - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2025-07-17T13:31:01+00:00","dateModified":"2025-07-17T13:31:41+00:00","description":"We are happy to announce that the ASCERTAIN project website is now accessible in eight different languages:English, German, Dutch, Norwegian, Romanian, Croatian, Spanish, and French.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/ascertain-consortium-meeting-in-oslo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/de\/startseite\/"},{"@type":"ListItem","position":2,"name":"ASCERTAIN Consortium Meeting in Oslo"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/posts\/4582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/comments?post=4582"}],"version-history":[{"count":3,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/posts\/4582\/revisions"}],"predecessor-version":[{"id":4595,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/posts\/4582\/revisions\/4595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/media?parent=4582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/categories?post=4582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/tags?post=4582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}